Skip to content
healthcare.dev

Ustilago Maidis

NDC 37662-2109, Ustilago Maidis, pellet, from Hahnemann Laboratories, INC..

Product NDC
37662-2109
Status
Listed
Labeler
Hahnemann Laboratories, INC.
Dosage form
PELLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/37662-2109 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • USTILAGO MAYDIS100 [hp_C]/1

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Fungal Allergenic Extract [EPC]

Package NDCNDC-11Package
37662-2109-137662210901200 PELLET in 1 VIAL, GLASS (37662-2109-1)
37662-2109-237662210902500 PELLET in 1 VIAL, GLASS (37662-2109-2)
37662-2109-3376622109033000 PELLET in 1 BOTTLE, GLASS (37662-2109-3)
37662-2109-43766221090410000 PELLET in 1 BOTTLE, GLASS (37662-2109-4)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 37662-2109 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/37662-2109 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 37662-2109. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.